90 related articles for article (PubMed ID: 9594635)
21. Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy.
Carril JM; Gómez-Barquín R; Quirce R; Tabuenca O; Uriarte I; Montero A
Anticancer Res; 1997; 17(3B):1677-81. PubMed ID: 9179217
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging.
Aktolun C
J Nucl Med; 1994 Dec; 35(12):2055-6. PubMed ID: 7989994
[No Abstract] [Full Text] [Related]
23. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
[TBL] [Abstract][Full Text] [Related]
24. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
[TBL] [Abstract][Full Text] [Related]
25. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
Aziz A; Hashmi R; Ogawa Y; Hayashi K
Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
[TBL] [Abstract][Full Text] [Related]
26. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
[TBL] [Abstract][Full Text] [Related]
27. New method for breast cancer detection using TC-99m sestamibi scintimammography.
Yuen-Green M; Wasnich R; Caindec-Ranchez S; Davis J
Hawaii Med J; 1996 Feb; 55(2):26-8. PubMed ID: 8820628
[TBL] [Abstract][Full Text] [Related]
28. Prone scintimammography in patients with non-palpable breast lesions.
Maffioli L; Agresti R; Chiti A; Crippa F; Gasparini M; Greco M; Bombardieri E
Anticancer Res; 1996; 16(3A):1269-73. PubMed ID: 8702249
[TBL] [Abstract][Full Text] [Related]
29. Breast-specific gamma imaging for detection of breast cancer.
Riordan W
Radiology; 2009 Apr; 251(1):306; author reply 306. PubMed ID: 19332861
[No Abstract] [Full Text] [Related]
30. 99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging.
Lu G; Shih WJ; Huang HY; Long MQ; Sun Q; Liu YH; Chou C
Nucl Med Commun; 1995 Mar; 16(3):150-6. PubMed ID: 7770238
[TBL] [Abstract][Full Text] [Related]
31. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions.
Cutrone JA; Yospur LS; Khalkhali I; Tolmos J; Devito A; Diggles L; Vargas MP; Shitabata P; French S
J Nucl Med; 1998 Mar; 39(3):449-53. PubMed ID: 9529290
[TBL] [Abstract][Full Text] [Related]
32. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
Maurer AH; Caroline DF; Jadali FJ; Manzone TA; Maier WP; Au FC; Schnall SF
J Nucl Med; 1995 Sep; 36(9):1696-700. PubMed ID: 7658233
[TBL] [Abstract][Full Text] [Related]
33. [Nuclear medical breast diagnosis--scintigraphy using 99mTc-sestamibi].
Hahn K
Nuklearmedizin; 1996 Jun; 35(3):4-6. PubMed ID: 8710527
[No Abstract] [Full Text] [Related]
34. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.
Cwikla JB; Buscombe JR; Kolasinska AD; Parbhoo SP; Thakrar DS; Hilson AJ
Anticancer Res; 1999; 19(3B):2299-304. PubMed ID: 10472348
[TBL] [Abstract][Full Text] [Related]
35. [Results of the European multicenter study of radionuclide mammography with Tc-99m-MIBI].
Grünwald F; Palmedo H; Mallmann P; Biersack HJ
Zentralbl Chir; 1998; 123 Suppl 5():47-8. PubMed ID: 10063572
[TBL] [Abstract][Full Text] [Related]
36. [Initial experiences with radionuclide mammography at the Cottbus Carl-Thiem Clinic].
Richter M; Dschietzig C; Romann D; Riedel HH
Zentralbl Chir; 1998; 123 Suppl 5():49-52. PubMed ID: 10063573
[TBL] [Abstract][Full Text] [Related]
37. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.
Omar WS; Eissa S; Moustafa H; Farag H; Ezzat I; Abdel-Dayem HM
Anticancer Res; 1997; 17(3B):1639-44. PubMed ID: 9179210
[TBL] [Abstract][Full Text] [Related]
38. [99mTc-MIBI uptake in breast abscess: a case report].
Ohta H
Kaku Igaku; 1999 Apr; 36(3):237-40. PubMed ID: 10358958
[TBL] [Abstract][Full Text] [Related]
39. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
[TBL] [Abstract][Full Text] [Related]
40. [Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
Prats E; Abós M; Aisa F; Villavieja L; Asenjo M; García-López F; Tomás A; Sainz J; Razola P; Banzo J
Rev Esp Med Nucl; 1998; 17(2):73-81. PubMed ID: 9611276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
